Affymax® to Present at the Morgan Stanley Global and the Deutsche Bank 32nd Annual Healthcare Conferences

Affymax® to Present at the Morgan Stanley Global and the Deutsche Bank 32nd Annual Healthcare Conferences

Affymax, Inc. (Nasdaq: AFFY) today announced that Arlene M. Morris, the company’s president and chief executive officer, will present at two upcoming healthcare conferences. Ms. Morris will present at the Morgan Stanley Global Healthcare Unplugged Conference on Wednesday, May 2, 2007 at 10:15 a.m. Eastern Time in Miami. The following day, Thursday, May 3, 2007, at 7:30 a.m. Eastern Time, she will present at the Deutsche Bank 32nd Annual Healthcare Conference being held in Washington, D.C.

A live webcast of the presentation will be available on the Investors section of the company’s website at www.affymax.com. A replay will also be available for 30 days following the presentation.

About Affymax, Inc.

Affymax, Inc. is a biopharmaceutical company developing novel peptide-based drugs to improve the treatment of serious and often life-threatening conditions. Affymax’s lead product candidate, Hematide™, is currently in Phase 2 clinical trials for the treatment of anemia associated with chronic kidney disease and cancer. For additional information, please visit www.affymax.com.
Contacts

Affymax, Inc.
Sylvia Wheeler, 650-812-8861
Executive Director, Investor Relations